These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34857456)

  • 21. Effect of sleeve gastrectomy bariatric surgery-induced weight loss on serum AMH levels in reproductive aged women.
    Bhandari S; Ganguly I; Bhandari M; Agarwal P; Singh A; Gupta N; Mishra A
    Gynecol Endocrinol; 2016 Oct; 32(10):799-802. PubMed ID: 27087540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery.
    Escobar-Morreale HF; Botella-Carretero JI; Alvarez-Blasco F; Sancho J; San Millán JL
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6364-9. PubMed ID: 16189250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive Function Abnormalities and Bariatric Surgery: Is a Matter of Time?
    Di Vincenzo A; Rossato M
    Obes Surg; 2019 Jan; 29(1):318-319. PubMed ID: 30397875
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
    Ságodi L; Barkai L
    Orv Hetil; 2013 Jan; 154(4):136-42. PubMed ID: 23335723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to "Reproductive Function Abnormalities and Bariatric Surgery: is a Matter of Time?".
    Christ J; Falcone T
    Obes Surg; 2019 Jan; 29(1):320-321. PubMed ID: 30552548
    [No Abstract]   [Full Text] [Related]  

  • 26. Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility.
    Butterworth J; Deguara J; Borg CM
    J Obes; 2016; 2016():1871594. PubMed ID: 27965894
    [No Abstract]   [Full Text] [Related]  

  • 27. Polycystic Ovary Disease and Obesity: Leptin, Weight-loss Medication, and Bariatric Surgery.
    Burgart JM
    Clin Obstet Gynecol; 2021 Mar; 64(1):90-95. PubMed ID: 33346596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome.
    Escobar-Morreale HF; Luque-Ramírez M; San-Millán JL
    Diabetes Care; 2009 Jan; 32(1):e6. PubMed ID: 19114623
    [No Abstract]   [Full Text] [Related]  

  • 29. [Menstrual cycle disorders in polycystic ovary syndrome--ultrasonographic characteristics and hormonal status].
    Radulović A; Bogavac M; Pjević Trninić A
    Med Pregl; 2002; 55(5-6):241-6. PubMed ID: 12170870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric disorders related to polycystic ovary syndrome.
    Krępuła K; Bidzińska-Speichert B; Lenarcik A; Tworowska-Bardzińska U
    Endokrynol Pol; 2012; 63(6):488-91. PubMed ID: 23339008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K; Njike V; Costales VC
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical features, reproductive endocrine and metabolic abnormalities of adolescent girls with polycystic ovary syndrome].
    Zhao Y; Xu JJ; Zhu MW; Lin JF
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(25):1729-34. PubMed ID: 20979887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of obesity on reproductive outcomes after ovarian ablative therapy in PCOS: a collaborative meta-analysis.
    Baghdadi LR; Abu Hashim H; Amer SA; Palomba S; Falbo A; Al-Ojaimi E; Ott J; Zhu W; Fernandez H; Nasr A; Ramzy AM; Clark J; Doi SA
    Reprod Biomed Online; 2012 Sep; 25(3):227-41. PubMed ID: 22809865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies.
    Behboudi-Gandevani S; Ramezani Tehrani F; Rostami Dovom M; Farahmand M; Bahri Khomami M; Noroozzadeh M; Kabir A; Azizi F
    Gynecol Endocrinol; 2016; 32(5):343-53. PubMed ID: 27052492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome.
    Chihal HJ; Baudier MM
    Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Bariatric Surgery on Clinical, Biochemical, and Hormonal Parameters in Women with Polycystic Ovary Syndrome (PCOS).
    Singh D; Arumalla K; Aggarwal S; Singla V; Ganie A; Malhotra N
    Obes Surg; 2020 Jun; 30(6):2294-2300. PubMed ID: 32088855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Raeisi T; Rezaie H; Darand M; Taheri A; Garousi N; Razi B; Roever L; Mohseni R; Hussien Mohammed S; Alizadeh S
    PLoS One; 2021; 16(3):e0246200. PubMed ID: 33740002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric Surgery: Does It Play a Role in Fertility-Preserving Treatment Among Obese Young Women With Endometrial Cancer?
    Benito V; López-Tomassetti E; Esparza M; Arencibia O; Andújar M; Prieto M; Lubrano A
    J Minim Invasive Gynecol; 2015; 22(5):906-9. PubMed ID: 25843520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.